Best in Class? The Comparative Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists in Preventing Incident CKD Stage 3 or Higher

2026-07-11

PRE

Allison C. Reaves

Mark J. Sarnak *

DOI：10.1053/j.ajkd.2026.07.001

Original request for help

Save

Abstract

IF:

8.2

Papers:

1.0W

Citations:

2.6W

No organization information available